Skip to content

Comparing the Outcome of transplanted Liver between Gas based and Intravenous based anesthesia Technique in the Donor surgery in Living Donor Liver Transplantation

Comparison of Graft Outcomes Between Inhalational and Intravenous Anaesthetic Agents for Donor Hepatectomy in Living Donor Liver Transplantation - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092127
Enrollment
100
Registered
2025-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: propofol: total intravenous anaesthesia. Propofol is routinely used to initiate general anesthesia. We have planned to maintain anesthesia with propofol infusion throuhout the surgery C

Sponsors

Dr. Rela institute and medical centre,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients coming for open right lobe donor hepatectomy

Exclusion criteria

Exclusion criteria: patient refusal patients with history of severe post-operative nausea and vomiting

Design outcomes

Primary

MeasureTime frame
To compare the Recipient s AST level on POD-1 between the grafts exposed to Sevoflurane and Propofol based TIVA Timepoint: first post-operative day

Secondary

MeasureTime frame
To compare the following parameters in the donors 1)Intraoperative hemodynamic parameters (number of episodes of hypotension, requirements of intermittent vasopressor boluses, if any) 2)Post-operative pain in the donor as measured by numerical rating scale 3)Post-operative morphine consumption (per day) until POD2 4)Incidence of Postoperative nausea & vomiting 5)Nasogastric tube aspiration quantity per day & requirement of prokinetic 6)Quality of recovery as measured by QoR 15 score Timepoint: Hourly in the intra-operative period & then daily for 7 days ;To compare the following in recipients 1)POD 1 to 7 bilirubin, transaminases, & prothrombin time (INR) 2)Incidence of graft dysfunction as per Olthoff s criteria Timepoint: Hourly in the intra-operative period & then daily for 7 days

Countries

India

Contacts

Public ContactDrAmal Francis Sam

Rela Hospital

amalfsam@gmail.com8968163281

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026